IDEXX Laboratories, Inc. (LON:0J8P)
London · Delayed Price · Currency is GBP · Price in USD 678.74
-11.62 (-1.68%)
At close: Jan 29, 2026
IDEXX Laboratories Market Cap
IDEXX Laboratories has a market cap or net worth of 39.87 billion as of January 29, 2026. Its market cap has increased by 40.07% in one year.
Market Cap
39.87B
Enterprise Value
40.53B
Revenue
3.10B
Ranking
n/a
PE Ratio
52.16
Stock Price
678.74
Market Cap Chart
Since June 21, 1991, IDEXX Laboratories's market cap has increased from 42.95M to 39.87B, an increase of 92,720.79%. That is a compound annual growth rate of 21.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 39.87B | -0.67% |
| Dec 31, 2025 | 40.14B | 48.43% |
| Dec 31, 2024 | 27.04B | -25.28% |
| Dec 29, 2023 | 36.19B | 29.06% |
| Dec 30, 2022 | 28.04B | -32.00% |
| Dec 31, 2021 | 41.23B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.27B |
| GSK plc | 74.73B |
| Haleon | 33.54B |
| Smith & Nephew | 10.56B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.42B |
| Genus | 1.99B |
| HUTCHMED (China) | 1.90B |